Catalysing Success in Life Sciences

OBN is a not-for-profit membership network that catalyses growth for the life sciences industry. Whether you’re an emerging entrepreneur, R&D SME, investor, analyst, pharma company, science park, TTO or technology / professional services organisation, we are here to give you opportunities to meet, learn, and grow. Read more about how we can help you to:

Create Connections Secure Investment Save Time & Money Join OBN

Patron

Join us at the next OBN event

Make connections and keep up to date with the latest life sciences industry innovations. View upcoming OBN and Member events.

09 Jun

8:30am – 6:30pm

etc.venues Fenchurch Street

BioSeed Edition 12

30 Sep

8:30am – 6:00pm

Oxford Technology Park

BioForward 2025

26 Nov

7:00pm – 11:00pm

Royal Lancaster London

OBN Awards 2025

We pride ourselves on supporting our members to catalyse their success.

We do this by keeping the life sciences community connected and informed, making us an essential partner.

But don’t take our word for it, here is what our members and partners say.

“At Oxford Endovascular we feel that OBN’s well informed team is really invested in our journey, supporting us as the business develops.”

Mike Karim Oxford Endovascular , CEO

“Through OBN we can make valuable connections with potential customers, keeping them informed about Biosynth’s products and services. Other advantages to being an OBN member include discounted rates for events and conference attendance.”

Adrian Hery Barranco Biosynth, Marketing & Business Development Officer

“I’ve met a number of amazing people through OBN, who are all so open to sharing their experience and helping to support emerging biotechs. I’d encourage everyone to join in, whether a seasoned industry insider, an emerging biotech with exciting science, or a sponsor aiming to build their brand and support new biotech – OBN is great!”

Nick Pumphrey Etcembly, CSO

Latest News

24/04/25 General

CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a…

23/04/25 General

Sensitive and specific DUB enzyme assay kits

22/04/25 General

aws Best of Biotech 2025: Submit Your Entry!

16/04/25 General

Coulter Partners announces successful placement of Chief Data and Technology Officer at Clinica…

15/04/25 General

Coulter Partners Top hires for VC & PE portfolio companies Q1-2025